Precigen (PGEN) Minority Interest (2013 - 2025)

Precigen's (PGEN) quarterly Minority Interest came in at $30.9 million in Q2 2025, up 4.62% on a QoQ basis from $29.5 million in Q1 2025.

Precigen (PGEN) Minority Interest (2013 - 2025) Analysis & Trends

Precigen (PGEN) has 9 years of Minority Interest data on file, last reported at $30.9 million in Q2 2025.

On a quarterly basis, Minority Interest changed N/A year-over-year to $30.9 million in Q2 2025; TTM through Jun 2025 was $30.9 million, a N/A change from a year earlier, with the FY2024 full-year figure at $28.2 million, changed N/A from the prior year.
Minority Interest for Q2 2025 stood at $30.9 million, up from $29.5 million in the prior quarter.
Over the last five years, Minority Interest for PGEN reached as high as $30.9 million in Q2 2025 and fell as low as $28.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Precigen	1.96 Bn	1.96 Bn	20.69 Mn

Download Data